Delaware Braces for Wave of Mass Tort Cases Following Crucial Expert Testimony Ruling in Zantac Litigation
Wilmington, DE — Delaware could soon witness a significant uptick in mass tort litigation due to a recent pivotal decision involving the heartburn medication Zantac. The decision, which allowed expert testimony linking the drug to cancer, stands to set a legal precedent impacting numerous pending cases and potentially drawing more to the state’s courts. The ruling originated from lawsuits alleging that ranitidine, the active ingredient in Zantac, produces high levels of the carcinogen N-nitrosodimethylamine (NDMA) when ingested. Plaintiffs argue that this has led to various cancers among users, sparking widespread concern and subsequent legal action. … Read more